CME CirclePrint this Activity for Offline ReferenceInstructions on Taking Medscape CME

New Perspectives on CMV and Other Viruses in the Immunocompromised Patient CME
W. Lawrence Drew, MD, PhD; Ajit Limaye, MD; Nina Singh,MD
Disclosures

Release Date: March 27, 2003; Valid for credit through March 27, 2004

This activity has expired.
CME in this activity indicates that it was developed according to ACCME guidelines and was certified for credit by one or more accredited CME or CE providers. Medscape cannot attest to the timeliness of expired CME activities.


This CME activity, "New Perspectives on CMV and Other Viruses in the Immunocompromised Patient," was originally offered as a CD-ROM certified for CME.

Contents of This CME Activity
  1. Clinical Implications of Antiviral Resistance in HIV/AIDS
    Use of Highly Active Antiretroviral Therapy for Cytomegalovirus Viremia
    The Gold Standard in Testing Resistance: IC50
    Testing Sensitivities/Resistance Among Agents
    What About IC50 Testing in Other Laboratories?
    The Mechanisms and Incidence of Resistant Cytomegalovirus
    Polymerase Mutations and Cross Resistance
    Prophylactic vs Preemptive Therapy and the Development of Resistance
    Approaches to Avoiding Resistance

  2. Clinical Implications of Antiviral Resistance in Transplantation
    Ganciclovir-Resistant Cytomegalovirus: Incidence, Resistance, and Risk Factors
    Analysis of Ganciclovir-Resistant Cytomegalovirus in Abdominal Organ Transplant Recipients
    Ganciclovir Resistance in Lung Transplant Recipients
    Diagnosis, Mechanisms, and Treatment of Ganciclovir-Resistant Cytomegalovirus

  3. Role of HHV-6 and BK Virus in Transplantation
    The Biology, Epidemiology, and Variants of Human Herpesvirus-6
    Human Herpesvirus-6 in the Setting of Organ Transplantation
    Human Herpesvirus-6 and Neurologic Complications
    Human Herpesvirus-6 and Associations With Invasive Fungal Infection and Hepatitis C Virus
    Effect of Treatment of Human Herpesvirus-6 on Outcome
    An Emerging Polyomavirus: The BK Virus
    Using Decoy Cells as Markers for BK Virus Nephropathy
    Other Markers for BK Viremia

These educational activities, certified by accredited providers, were not prepared by Medscape's editors, but are made available on our site as a service to our audience. Authors are routinely instructed by the provider to disclose significant financial relationships and mention of investigational drugs and unapproved indications. Medscape has received a fee for posting these activities. Direct questions or comments to: CME@webmd.net.

 
Legal Disclaimer
The material presented here does not necessarily reflect the views of Medscape, The University of Minnesota, the companies providing educational grants or the authors and writers. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. All readers and continuing education participants should verify all information and consult a qualified healthcare professional before treating patients or utilizing any therapeutic product discussed in this educational activity.

 
Copyright © 2003 by The University of Minnesota.
Roche
  • This activity has expired.

    The accredited provider can no longer issue certificates for this activity. Medscape cannot attest to the timeliness of expired CME activities.

  • CME Information
All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.